If you are wondering whether AstraZeneca shares are offering fair value at current levels, this breakdown will help you connect the recent share price with what the underlying business might justify.

Fintel reports that on January 27, 2026, Citigroup initiated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) ...

How AstraZeneca’s recent performance may look to long term holders AstraZeneca (LSE:AZN) shares have moved mixed recently, with a 2.7% decline over the past day, a small gain over the past week, a 1.7 ...

Astrazeneca (AZN) closed the most recent trading day at $94.23, moving +1.38% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.5%. At the same ...

Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.

AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory review after strong trial results.

AstraZeneca Pharma, in an exchange filing, said it has received the CDSCO's permission to import for sales and distribution of the solution for infusion 120 mg/2.4 ml and 500mg/10 ml for an additional ...

CSPC said earlier Friday that it entered an obesity drug agreement with AstraZeneca that would give the U.K.-based pharmaceutical company rights outside China to its clinical-ready long-acting obesity ...

Under the deal, the FTSE 100 group will have the exclusive global rights, outside China, to CSPC's once-a-month jab that is about to start early-stage clinical trials.

AstraZeneca (NASDAQ:AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

FTSE 100 Live 30 January: Gold and silver prices slump, AstraZeneca strikes China deal - ...